The Food and Drug Administration approved rituximab in combination with chemotherapy for the treatment of pediatric patients with 4 different types of previously untreated, advanced stage blood cancers.
FDA Approvals
The Food and Drug Administration approved rituximab in combination with chemotherapy for the treatment of pediatric patients with 4 different types of previously untreated, advanced stage blood cancers.
FDA Approvals
